Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Vauxhall › NPI 1164578894

Associated Retinal Consultants LLC

Associated Retinal Consultants LLC was paid $25.19M by Medicaid between Jan 2018 and Nov 2024, across 50 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 42% of everything it billed.

33Billing provider infoASSOCIATED RETINAL CONSULTANTS LLC
VAUXHALL, NJ 07088
33aNPI1164578894assigned 01/26/2007
33bProvider typeOptometrist
28Total paid$25.19M
24GClaims403,720
24DCodes billed50
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Optometrist providers in New Jersey

Rank by total paid#1 of 599
Median peer was paid$2K
This provider vs. median13,999×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201872,788$2.58M
201939,869$2.61M
202023,357$2.02M
202142,867$3.17M
202268,799$4.76M
202391,487$6.12M
2024incomplete64,553$3.93M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J0178 Injection, aflibercept, 1 mg 42% 12,624 9,035 $10.50M
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 19% 79,089 65,080 $4.74M
67028 Intravitreal injection of a pharmacologic agent 11% 53,087 39,062 $2.68M
92134 8.6% 94,498 78,226 $2.17M
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 3.9% 8,782 7,850 $990K
J0177 Injection, aflibercept hd, 1 mg 2.3% 1,077 611 $585K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 1.7% 3,436 3,270 $434K
J2778 Injection, ranibizumab, 0.1 mg 1.6% 572 519 $400K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.4% 5,078 4,392 $361K
92226 1.3% 21,371 13,997 $327K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.2% 6,805 5,666 $310K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 1.1% 6,021 5,090 $286K
38 more codes
J9035 Injection, bevacizumab, 10 mg 1.0% 4,607 $257K
92202 <1% 33,530 $246K
92250 <1% 4,524 $188K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 557 $145K
92201 <1% 6,519 $111K
92015 Determination of refractive state <1% 8,113 $99K
92060 <1% 1,517 $96K
92225 <1% 4,042 $80K
92235 <1% 406 $31K
99244 Office or other outpatient consultation, moderate to high complexity <1% 124 $23K
J3590 Unclassified biologics <1% 288 $22K
J2777 Injection, faricimab-svoa, 0.1 mg <1% 46 $22K
92136 <1% 952 $20K
92083 <1% 433 $13K
92340 Fitting of spectacles, except for aphakia; monofocal <1% 670 $13K
92133 <1% 525 $11K
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg <1% 14 $7K
92020 <1% 520 $6K
99222 Initial hospital care, per day, moderate complexity <1% 26 $3K
99203 Doctor's office visit, new patient (routine) <1% 28 $3K
99205 Prolong outpt/office vis <1% 14 $3K
76512 <1% 18 $633.52
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 14 $597.63
J7999 Compounded drug, not otherwise classified <1% 321 $482.22
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications <1% 9,857 $370.34
4040F <1% 5,108 $45.97
1036F 0% 9,334 $0.00
4177F 0% 1,079 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 0% 3,656 $0.00
G8397 Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy 0% 2,787 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 0% 48 $0.00
2019F 0% 625 $0.00
2023F 0% 25 $0.00
2022F 0% 3,488 $0.00
2021F 0% 2,710 $0.00
G8482 Influenza immunization administered or previously received 0% 1,540 $0.00
5010F 0% 2,798 $0.00
G9974 Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity 0% 417 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMADREPERLA, STEVEN (OWNER/CEO)
Same official

Other billing entities under MADREPERLA, STEVEN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.